Summary
The absorption of Adriamycin® (ADM) into the systemic circulation after intravesical administration, using an experimental model in the rat,was closely related to the volume of the instilled solution and the concentration of the drug. The post instillation plasma concentration of ADM was increased after addition of Tween 80 to the instilled solution but the magnitude of the absorption was still discreet and, from a clinical point of view, negligible.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bridges J, Sargent N, Upshall D (1979) Rapid absorption from the urinary bladder of a series of n-alkyl carbamates: a route for the recirculation of drugs. Br J Pharmacol 66:283–289
Colleen S, Ek A, Hellsten S, Lindholm C (1980) Intracavitary Epodyl® for multiple, non-invasive, highly differentiated bladder tumours. Scand J Urol Nephrol 14:43–45
Edsmyr F, Berlin T, Boman J, Duchek M, Esposti P, Gustafsson H, Wijkström H, Collste L (1980) Intravesical therapy with adriamycin in patients with superficial bladder tumors. Eur Urol 6:132–136
Ek A, Hellsten S, Henriksson H, Idwall I, Lindholm C, Lindholm K, Mikulowski P, Månsson W (1984) Intravesical adriamycin therapy in carcinoma in situ of the urinary bladder. Scand J Urol Nephrol 18:131–134
Eksborg S, Ehrsson H, Andersson I (1979) Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol. J Chromatogr 164:479–486
Eksborg S, Nilsson S-O, Edsmyr F (1980) Intravesical instillation of Adriamycin®. Eur Urol 6:218–220
Eksborg S, Edsmyr F, Näslund I (1982) Intravesical instillation with adriamycin + Tween 80 in patients with superficial bladder tumors. Eur Urol 8:213–215
Engelmann U, Bürger R, Rumpelt J, Jacobi G (1983) Adriamycin permeability of the rat bladder under different conditions. J Urol 129:862–864
Green D, Robinson M, Glashan R, Newling D, Dalesio O, Smith P (1984) Does intravesical chemotherapy prevent invasive bladder cancer? J Urol 131:33–35
Huland H, Otto U (1983) Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of a controlled, prospective study in 58 patients. Eur Urol 9:84–86
Jacobi G, Kurth K-H (1980) Studies on the intravesical action of topically administered G3 H-Doxorubicin hydrochloride in mean: plasma uptake and tumor penetration. J Urol 124:34–37
Larson A, Eksborg S, Fritjofsson Å(1984)Intravesical instillation of adriamycin early after transurethral resection: Measurements of plasma levels. Eur Urol 10:398–400
Lundbeck F, Mogensen P, Jeppesen N (1983) Intravesical therapy of noninvasive bladder tumors(stage Ta) with Doxorubicin and urokinase. J Urol 130:1087–1089
Pavone-Macaluso M, Ingargiola G (1980) Local chemotherapy in bladder cancer treatment. Oncology 37:71–76
Riddle P (1973) The management of superficial bladder tumours with intravesical epodyl. Br J Urol 45:84–87
Soloway M, Murphy W, DeFuria M, Crooke S, Finebaum P (1981) The effect of Mitomycin C on superficial bladder cancer. J Urol 125:646–648
Veenema R, Dean A, Roberts M, Fingerhut B, Chowhury B, Tarassoly T (1962) Bladder carcinoma treated by direct instillations of thiotepa. J Urol 88:60–63
Weisenthal L, Lalude A, Miller J, (1983) In vitro chemosensitivity of human bladder cancer. Cancer 51:1490–1496
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hellsten, S., Eksborg, S. & Axelsson, B. Absorption of Adriamycin® into the systemic circulation after intravesical instillation with or without tween 80 in the rat. Urol. Res. 15, 21–23 (1987). https://doi.org/10.1007/BF00256330
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00256330